203 related articles for article (PubMed ID: 12200048)
1. The role of the proteasome activator PA28 in MHC class I antigen processing.
Sijts A; Sun Y; Janek K; Kral S; Paschen A; Schadendorf D; Kloetzel PM
Mol Immunol; 2002 Oct; 39(3-4):165-9. PubMed ID: 12200048
[TBL] [Abstract][Full Text] [Related]
2. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
[TBL] [Abstract][Full Text] [Related]
3. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
van Hall T ; Sijts A; Camps M; Offringa R; Melief C; Kloetzel PM; Ossendorp F
J Exp Med; 2000 Aug; 192(4):483-94. PubMed ID: 10952718
[TBL] [Abstract][Full Text] [Related]
4. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
Sijts A; Zaiss D; Kloetzel PM
Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of proteasome activator PA28-beta subunit of large yellow croaker (Pseudosciana crocea) and its coordinated up-regulation with MHC class I alpha-chain and beta 2-microglobulin in poly I:C-treated fish.
Liu G; Zheng W; Chen X
Mol Immunol; 2007 Feb; 44(6):1190-7. PubMed ID: 16901544
[TBL] [Abstract][Full Text] [Related]
7. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.
Li J; Schuler-Thurner B; Schuler G; Huber C; Seliger B
Int Immunol; 2001 Dec; 13(12):1515-23. PubMed ID: 11717192
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
[TBL] [Abstract][Full Text] [Related]
9. The proteasome and MHC class I antigen processing.
Kloetzel PM
Biochim Biophys Acta; 2004 Nov; 1695(1-3):225-33. PubMed ID: 15571818
[TBL] [Abstract][Full Text] [Related]
10. Allele-selective effect of PA28 in MHC class I antigen processing.
Yamano T; Sugahara H; Mizukami S; Murata S; Chiba T; Tanaka K; Yui K; Udono H
J Immunol; 2008 Aug; 181(3):1655-64. PubMed ID: 18641301
[TBL] [Abstract][Full Text] [Related]
11. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.
de Graaf N; van Helden MJ; Textoris-Taube K; Chiba T; Topham DJ; Kloetzel PM; Zaiss DM; Sijts AJ
Eur J Immunol; 2011 Apr; 41(4):926-35. PubMed ID: 21360704
[TBL] [Abstract][Full Text] [Related]
12. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
13. A role for the proteasome regulator PA28alpha in antigen presentation.
Groettrup M; Soza A; Eggers M; Kuehn L; Dick TP; Schild H; Rammensee HG; Koszinowski UH; Kloetzel PM
Nature; 1996 May; 381(6578):166-8. PubMed ID: 8610016
[TBL] [Abstract][Full Text] [Related]
14. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.
Kloetzel PM; Ossendorp F
Curr Opin Immunol; 2004 Feb; 16(1):76-81. PubMed ID: 14734113
[TBL] [Abstract][Full Text] [Related]
15. Impaired immunoproteasome assembly and immune responses in PA28-/- mice.
Preckel T; Fung-Leung WP; Cai Z; Vitiello A; Salter-Cid L; Winqvist O; Wolfe TG; Von Herrath M; Angulo A; Ghazal P; Lee JD; Fourie AM; Wu Y; Pang J; Ngo K; Peterson PA; Früh K; Yang Y
Science; 1999 Dec; 286(5447):2162-5. PubMed ID: 10591649
[TBL] [Abstract][Full Text] [Related]
16. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
Yang B; Hahn YS; Hahn CS; Braciale TJ
J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
[TBL] [Abstract][Full Text] [Related]
17. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer.
Cerruti F; Martano M; Petterino C; Bollo E; Morello E; Bruno R; Buracco P; Cascio P
Neoplasia; 2007 Nov; 9(11):960-9. PubMed ID: 18030364
[TBL] [Abstract][Full Text] [Related]
19. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.
Shimbara N; Nakajima H; Tanahashi N; Ogawa K; Niwa S; Uenaka A; Nakayama E; Tanaka K
Genes Cells; 1997 Dec; 2(12):785-800. PubMed ID: 9544705
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing.
Yamano T; Murata S; Shimbara N; Tanaka N; Chiba T; Tanaka K; Yui K; Udono H
J Exp Med; 2002 Jul; 196(2):185-96. PubMed ID: 12119343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
